-
1
-
-
0347694556
-
Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid
-
14711073 10.1016/S0891-5520(03)00065-5
-
Craig WA (2003) Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am 17:479-501
-
(2003)
Infect Dis Clin North Am
, vol.17
, pp. 479-501
-
-
Craig, W.A.1
-
2
-
-
66449092115
-
A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics
-
19384201 10.1097/CCM.0b013e3181a0054d 1:CAS:528:DC%2BD1MXmtVKlu7g%3D
-
Roberts JA, Webb S, Paterson D, Ho KM, Lipman J (2009) A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med 37:2071-2078
-
(2009)
Crit Care Med
, vol.37
, pp. 2071-2078
-
-
Roberts, J.A.1
Webb, S.2
Paterson, D.3
Ho, K.M.4
Lipman, J.5
-
3
-
-
84859170733
-
Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: Systematic review and meta-analysis
-
22028203 10.1093/jac/dkr442 1:CAS:528:DC%2BC3MXhs1CqtLnO
-
Cataldo MA, Tacconelli E, Grilli E, Pea F, Petrosillo N (2012) Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother 67:17-24
-
(2012)
J Antimicrob Chemother
, vol.67
, pp. 17-24
-
-
Cataldo, M.A.1
Tacconelli, E.2
Grilli, E.3
Pea, F.4
Petrosillo, N.5
-
4
-
-
17944367778
-
Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: Prospective multicenter randomized study
-
11502515 10.1128/AAC.45.9.2460-2467.2001 1:CAS:528:DC%2BD3MXmt1emsb4%3D
-
Wysocki M, Delatour F, Faurisson F, Rauss A, Pean Y, Misset B, Thomas F, Timsit JF, Similowski T, Mentec H, Mier L, Dreyfuss D (2001) Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother 45:2460-2467
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 2460-2467
-
-
Wysocki, M.1
Delatour, F.2
Faurisson, F.3
Rauss, A.4
Pean, Y.5
Misset, B.6
Thomas, F.7
Timsit, J.F.8
Similowski, T.9
Mentec, H.10
Mier, L.11
Dreyfuss, D.12
-
5
-
-
77950303985
-
Nationwide implementation of antibiotic management teams in Belgian hospitals: A self-reporting survey
-
Hospital Medicine Working Group of the Belgian Antibiotic Policy Coordination Committee 20053695 10.1093/jac/dkp470
-
Van Gastel E, Costers M, Peetermans WE, Struelens MJ; Hospital Medicine Working Group of the Belgian Antibiotic Policy Coordination Committee (2010) Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey. J Antimicrob Chemother 65:576-580
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 576-580
-
-
Van Gastel, E.1
Costers, M.2
Peetermans, W.E.3
Struelens, M.J.4
-
6
-
-
78049244903
-
Importance of infusion volume and pump characteristics in extended administration of β-lactam antibiotics
-
20823285 10.1128/AAC.00754-10 1:CAS:528:DC%2BC3cXhsVCitrnO
-
Claus B, Buyle F, Robays H, Vogelaers D (2010) Importance of infusion volume and pump characteristics in extended administration of β-lactam antibiotics. Antimicrob Agents Chemother 54:4950
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 4950
-
-
Claus, B.1
Buyle, F.2
Robays, H.3
Vogelaers, D.4
-
7
-
-
34547578647
-
Peripheral line dead space: An unrecognised phenomenon?
-
17652677 10.1136/emj.2007.046250
-
Geggie D, Moore D (2007) Peripheral line dead space: an unrecognised phenomenon? Emerg Med J 24:558-559
-
(2007)
Emerg Med J
, vol.24
, pp. 558-559
-
-
Geggie, D.1
Moore, D.2
-
8
-
-
0003465792
-
-
22nd edn. Belgian/Luxembourg version. Belgian/Luxembourg Working Party on Antimicrobial Therapy. ISBN 978-1-930808-63-3
-
Sanford JP, Gilbert D, Chambers H, Eliopoulos GM, Moellering R, Saag M (2010) The Sanford guide to antimicrobial therapy, 2010-2011, 22nd edn. Belgian/Luxembourg version. Belgian/Luxembourg Working Party on Antimicrobial Therapy. ISBN 978-1-930808-63-3
-
(2010)
The Sanford Guide to Antimicrobial Therapy, 2010-2011
-
-
Sanford, J.P.1
Gilbert, D.2
Chambers, H.3
Eliopoulos, G.M.4
Moellering, R.5
Saag, M.6
-
11
-
-
84864237868
-
Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?
-
22747633 10.1186/2110-5820-2-22
-
Van Herendael B, Jeurissen A, Tulkens PM, Vlieghe E, Verbrugghe W, Jorens PG, Ieven M (2012) Continuous infusion of antibiotics in the critically ill: the new holy grail for beta-lactams and vancomycin? Ann Intensive Care 2:22
-
(2012)
Ann Intensive Care
, vol.2
, pp. 22
-
-
Van Herendael, B.1
Jeurissen, A.2
Tulkens, P.M.3
Vlieghe, E.4
Verbrugghe, W.5
Jorens, P.G.6
Ieven, M.7
-
12
-
-
34548401204
-
Continuous infusion of beta-lactams
-
17762242 10.1097/MCC.0b013e3282e2a98f
-
Mouton JW, Vinks AA (2007) Continuous infusion of beta-lactams. Curr Opin Crit Care 13:598-606
-
(2007)
Curr Opin Crit Care
, vol.13
, pp. 598-606
-
-
Mouton, J.W.1
Vinks, A.A.2
-
13
-
-
72449120921
-
First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis
-
20018492 10.1016/j.ijantimicag.2009.10.008 1:CAS:528:DC%2BD1MXhs1WltbrE
-
Roberts JA, Kirkpatrick CM, Roberts MS, Dalley AJ, Lipman J (2010) First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis. Int J Antimicrob Agents 35:156-163
-
(2010)
Int J Antimicrob Agents
, vol.35
, pp. 156-163
-
-
Roberts, J.A.1
Kirkpatrick, C.M.2
Roberts, M.S.3
Dalley, A.J.4
Lipman, J.5
-
14
-
-
84858285471
-
Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients
-
22333933 10.1016/j.ijantimicag.2011.12.008 1:CAS:528:DC%2BC38XitFyhsLc%3D
-
Ocampos-Martinez E, Penaccini L, Scolletta S, Abdelhadii A, Devigili A, Cianferoni S, de Backer D, Jacobs F, Cotton F, Vincent JL, Taccone FS (2012) Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients. Int J Antimicrob Agents 39:332-337
-
(2012)
Int J Antimicrob Agents
, vol.39
, pp. 332-337
-
-
Ocampos-Martinez, E.1
Penaccini, L.2
Scolletta, S.3
Abdelhadii, A.4
Devigili, A.5
Cianferoni, S.6
De Backer, D.7
Jacobs, F.8
Cotton, F.9
Vincent, J.L.10
Taccone, F.S.11
-
15
-
-
84856248934
-
Simple approach to improving vancomycin dosing in intensive care: A standardised loading dose results in earlier therapeutic levels
-
22276559 10.1111/j.1445-5994.2011.02459.x 1:CAS:528:DC%2BC38Xjslejtbk%3D
-
Truong J, Levkovich BJ, Padiglione AA (2012) Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels. Intern Med J 42:23-29
-
(2012)
Intern Med J
, vol.42
, pp. 23-29
-
-
Truong, J.1
Levkovich, B.J.2
Padiglione, A.A.3
-
16
-
-
82955212736
-
Improving vancomycin prescription in critical illness through a drug use evaluation process: A weight-based dosing intervention study
-
22024354 10.1016/j.ijantimicag.2011.08.017
-
Li J, Udy AA, Kirkpatrick CM, Lipman J, Roberts JA (2012) Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study. Int J Antimicrob Agents 39:69-72
-
(2012)
Int J Antimicrob Agents
, vol.39
, pp. 69-72
-
-
Li, J.1
Udy, A.A.2
Kirkpatrick, C.M.3
Lipman, J.4
Roberts, J.A.5
-
17
-
-
62449183879
-
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
-
19106348 10.2146/ajhp080434 1:CAS:528:DC%2BD1MXhs1Gmtrs%3D
-
Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, Dalovisio JR, Levine DP (2009) Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 66:82-98
-
(2009)
Am J Health Syst Pharm
, vol.66
, pp. 82-98
-
-
Rybak, M.1
Lomaestro, B.2
Rotschafer, J.C.3
Moellering, Jr.R.4
Craig, W.5
Billeter, M.6
Dalovisio, J.R.7
Levine, D.P.8
-
18
-
-
77954078062
-
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock
-
20594297 10.1186/cc9091
-
Taccone FS, Laterre PF, Dugernier T, Spapen H, Delattre I, Wittebole X, De Backer D, Layeux B, Wallemacq P, Vincent JL, Jacobs F (2010) Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care 14:R126
-
(2010)
Crit Care
, vol.14
, pp. 126
-
-
Taccone, F.S.1
Laterre, P.F.2
Dugernier, T.3
Spapen, H.4
Delattre, I.5
Wittebole, X.6
De Backer, D.7
Layeux, B.8
Wallemacq, P.9
Vincent, J.L.10
Jacobs, F.11
-
19
-
-
77954849218
-
Therapeutic drug monitoring of beta-lactams in critically ill patients: Proof of concept
-
20685085 10.1016/j.ijantimicag.2010.06.008 1:CAS:528:DC%2BC3cXhtVKjt7fN
-
Roberts JA, Ulldemolins M, Roberts MS, McWhinney B, Ungerer J, Paterson DL, Lipman J (2010) Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept. Int J Antimicrob Agents 36:332-339
-
(2010)
Int J Antimicrob Agents
, vol.36
, pp. 332-339
-
-
Roberts, J.A.1
Ulldemolins, M.2
Roberts, M.S.3
McWhinney, B.4
Ungerer, J.5
Paterson, D.L.6
Lipman, J.7
-
20
-
-
84863807810
-
Subtherapeutic initial beta-lactam concentrations in select critically ill patients: Association between augmented renal clearance and low trough drug concentrations
-
22194591 10.1378/chest.11-1671 1:CAS:528:DC%2BC38Xht1GmtrvL
-
Udy AA, Varghese JM, Altukroni M, Briscoe S, McWhinney BC, Ungerer JP, Lipman J, Roberts JA (2012) Subtherapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest 142:30-39
-
(2012)
Chest
, vol.142
, pp. 30-39
-
-
Udy, A.A.1
Varghese, J.M.2
Altukroni, M.3
Briscoe, S.4
McWhinney, B.C.5
Ungerer, J.P.6
Lipman, J.7
Roberts, J.A.8
-
21
-
-
66149108761
-
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients
-
19223642 10.1128/AAC.01149-08 1:CAS:528:DC%2BD1MXlvVGgtLo%3D
-
Pea F, Furlanut M, Negri C, Pavan F, Crapis M, Cristini F, Viale P (2009) Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients. Antimicrob Agents Chemother 53:1863-1867
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 1863-1867
-
-
Pea, F.1
Furlanut, M.2
Negri, C.3
Pavan, F.4
Crapis, M.5
Cristini, F.6
Viale, P.7
-
22
-
-
77349091306
-
Dosage adjustment of vancomycin in continuous infusion in critically-ill patients
-
20074899 10.1016/j.annfar.2009.12.002 1:STN:280:DC%2BC3c7jsFOnsw%3D%3D
-
Carricajo A, Forgeot A, Morel J, Auboyer C, Zeni F, Aubert G (2010) Dosage adjustment of vancomycin in continuous infusion in critically-ill patients. Ann Fr Anesth Reanim 29:55-57
-
(2010)
Ann Fr Anesth Reanim
, vol.29
, pp. 55-57
-
-
Carricajo, A.1
Forgeot, A.2
Morel, J.3
Auboyer, C.4
Zeni, F.5
Aubert, G.6
-
23
-
-
84858290068
-
Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients
-
10.1186/2110-5820-1-26
-
Spapen HD, Janssen van Doorn K, Diltoer M, Verbrugghe W, Jacobs R, Dobbeleir N, Honoré PM, Jorens PG (2011) Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients. Ann Intensive Care 19:26
-
(2011)
Anna Intensive Care
, vol.19
, pp. 26
-
-
Spapen, H.D.1
Janssen Van Doorn, K.2
Diltoer, M.3
Verbrugghe, W.4
Jacobs, R.5
Dobbeleir, N.6
Honoré, P.M.7
Jorens, P.G.8
-
24
-
-
45749083759
-
Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy
-
18334494 10.1093/jac/dkn080 1:CAS:528:DC%2BD1cXnt1Smsrg%3D
-
Ingram PR, Lye DC, Tambyah PA, Goh WP, Tam VH, Fisher DA (2008) Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy. J Antimicrob Chemother 62:168-171
-
(2008)
J Antimicrob Chemother
, vol.62
, pp. 168-171
-
-
Ingram, P.R.1
Lye, D.C.2
Tambyah, P.A.3
Goh, W.P.4
Tam, V.H.5
Fisher, D.A.6
-
25
-
-
80054681544
-
Vancomycin nephrotoxicity: Myths and facts
-
21978980 1:STN:280:DC%2BC3Mfptlahtw%3D%3D
-
Gupta A, Biyani M, Khaira A (2011) Vancomycin nephrotoxicity: myths and facts. Neth J Med 69:379-383
-
(2011)
Neth J Med
, vol.69
, pp. 379-383
-
-
Gupta, A.1
Biyani, M.2
Khaira, A.3
-
26
-
-
0037339053
-
Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units
-
12615867 10.1093/jac/dkg134 1:CAS:528:DC%2BD3sXit12ltL0%3D
-
Baririan N, Chanteux H, Viaene E, Servais H, Tulkens PM (2003) Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units. J Antimicrob Chemother 51:651-658
-
(2003)
J Antimicrob Chemother
, vol.51
, pp. 651-658
-
-
Baririan, N.1
Chanteux, H.2
Viaene, E.3
Servais, H.4
Tulkens, P.M.5
-
27
-
-
2342635820
-
Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis
-
15189746 10.1016/S0149-2918(04)90051-3 1:CAS:528:DC%2BD2cXkvF2nt7Y%3D
-
Kuti JL, Nightingale CH, Knauft RF, Nicolau DP (2004) Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis. Clin Ther 26:493-501
-
(2004)
Clin Ther
, vol.26
, pp. 493-501
-
-
Kuti, J.L.1
Nightingale, C.H.2
Knauft, R.F.3
Nicolau, D.P.4
-
28
-
-
77953710477
-
Stability of meropenem and doripenem solutions for administration by continuous infusion
-
20176578 10.1093/jac/dkq044 1:CAS:528:DC%2BC3cXks1Gnu7g%3D
-
Berthoin K, Le Duff CS, Marchand-Brynaert J, Carryn S, Tulkens PM (2010) Stability of meropenem and doripenem solutions for administration by continuous infusion. J Antimicrob Chemother 65:1073-1075
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 1073-1075
-
-
Berthoin, K.1
Le Duff, C.S.2
Marchand-Brynaert, J.3
Carryn, S.4
Tulkens, P.M.5
|